SynthesisBMC cancer2024

Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.

Zhilin Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.